|
Real-time
Boerse Muenchen
06:43:35 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 24.80 EUR | 0.00% |
|
+10.71% | -40.95% |
| 08-13 | Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement | MT |
| 08-06 | Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026 | CI |
Company Valuation: Collegium Pharmaceutical, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 650 | 778.9 | 1,004 | 924 | 1,464 | 935.6 | - | - |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -36.07% | - | - |
| Enterprise Value (EV) | 650 | 778.9 | 1,004 | 924 | 1,464 | 935.6 | 935.6 | 935.6 |
| Change | - | 19.82% | 28.87% | -7.95% | 58.4% | -36.07% | 0% | 0% |
| P/E | 10x | -31.4x | 23.9x | 15.4x | 26.8x | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | -0x | 0.3x | -3.83x | - | - | - |
| Capitalization / Revenue | 2.35x | 1.68x | 1.77x | 1.46x | 1.88x | 1.12x | 1.13x | 1.14x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.12x | 1.13x | 1.14x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 2.05x | 2.34x | 2.73x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 2.08x | 2.31x | 2.49x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.86 | -0.74 | 1.29 | 1.86 | 1.73 | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 276.9 | 463.9 | 566.8 | 631.4 | 780.6 | 836.8 | 828.1 | 820.2 |
| EBITDA 1 | 118.3 | 266 | 367 | 401.2 | 460.5 | 455.8 | 399.4 | 342.7 |
| EBIT 1 | 17.63 | 33.32 | 167 | 169.9 | 179.6 | 450.8 | 404.7 | 376.5 |
| Net income | 71.52 | -25 | 48.16 | 69.19 | 62.87 | - | - | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 18.68 | 23.20 | 30.78 | 28.65 | 46.30 | 28.74 | 28.74 | 28.74 |
| Nbr of stocks (in thousands) | 34,797 | 33,572 | 32,611 | 32,250 | 31,611 | 32,556 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/22/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.57x | 13.2x | 26.79x | 0.54% | 1,141B | |
| 30.41x | - | - | 1.96% | 659B | |
| 33.95x | 7.85x | 16.34x | 2.58% | 470B | |
| 20.47x | 4.85x | 12.03x | 2.72% | 366B | |
| 22.39x | 5.8x | 14.38x | 2.75% | 302B | |
| 21x | 4.33x | 12.29x | 2.03% | 254B | |
| 27.98x | 7.21x | 12.8x | 2.28% | 239B | |
| 13.62x | 4.84x | 10.15x | 3.77% | 207B | |
| -45.1x | 6.51x | 25.42x | 2.23% | 183B | |
| Average | 17.92x | 6.82x | 16.27x | 2.32% | 424.55B | |
| Weighted average by Cap. | 25.80x | 8.63x | 18.95x | 1.88% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
- Valuation Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
